Work

Comparative Efficacy of Once-Daily Umeclidinium and Twice-Daily Salmeterol in Symptomatic Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: Results from the EMAX Trial

Year: 2019

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3320

Authors: E.M. Kerwin, C. Vogelmeier, L. Bjermer, F. Maltais, M.L. Watkins, L. Tombs, I. Naya, I. Boucot, D.A. Lipson, C. Compton, P. Jones, on behalf of the EMAX study group

Institutions: Philipps University of Marburg, Lund University, Institut universitaire de cardiologie et de pneumologie de Québec, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (Germany), GlaxoSmithKline (United States)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2970156338

Cites:

Cited by:

Related to: 10